Ekman P - Search Results

1

Scandinavian clinical study of finasteride in the treatment of benign prostatic hyperplasia.

Beisland HO, Binkowitz B, Brekkan E, Ekman P, Kontturi M, Lehtonen T, Lundmo P, Pappas F, Round E, Shapiro D, et al. Beisland HO, et al. Among authors: ekman p. Eur Urol. 1992;22(4):271-7. doi: 10.1159/000474771. Eur Urol. 1992. PMID: 1283370 Clinical Trial.

2

[Treatment of benign prostatic hyperplasia with Proscar (finasteride). Results of a 10-year Scandinavian study].

Tveter KJ, Beisland HO, Andersen JT, Wolf H, Ekman P, Johansson JE, Kontturi M, Lehtonen T. Tveter KJ, et al. Among authors: ekman p. Tidsskr Nor Laegeforen. 1996 Nov 10;116(27):3226-30. Tidsskr Nor Laegeforen. 1996. PMID: 9011975 Clinical Trial. Norwegian.

3

Can finasteride reverse the progress of benign prostatic hyperplasia? A two-year placebo-controlled study. The Scandinavian BPH Study Group.

Andersen JT, Ekman P, Wolf H, Beisland HO, Johansson JE, Kontturi M, Lehtonen T, Tveter K. Andersen JT, et al. Among authors: ekman p. Urology. 1995 Nov;46(5):631-7. doi: 10.1016/s0090-4295(99)80291-x. Urology. 1995. PMID: 7495111 Clinical Trial.

4

[Finanseride in symtomatic benign prostatic hyeprtrophy. A 2-year placebo-controlled study].

Andersen JT, Wolf H, Ekman P, Beisland HO, Johansson JE, Kontturi M, Lehtonen T, Tveter K. Andersen JT, et al. Among authors: ekman p. Ugeskr Laeger. 1996 Sep 2;158(36):5030-5. Ugeskr Laeger. 1996. PMID: 8928243 Clinical Trial. Danish.

5

[Can finasteride reverse the progress of benign prostatic hyperplasia? A two-year placebo-controlled study.].

Einarsson GV, Andersen JT, Gislason T, Wolf H, Ekman P, Beisland HO, Johansson JE, Kontturi M, Lehtonen T, Tveter K. Einarsson GV, et al. Among authors: ekman p. Laeknabladid. 1996 Dec;82(12):859-66. Laeknabladid. 1996. PMID: 20065399 Icelandic.

6

Maximum efficacy of finasteride is obtained within 6 months and maintained over 6 years. Follow-up of the Scandinavian Open-Extension Study. The Scandinavian Finasteride Study Group.

Ekman P. Ekman P. Eur Urol. 1998;33(3):312-7. doi: 10.1159/000019566. Eur Urol. 1998. PMID: 9555559 Clinical Trial.

7

Tumor markers. Consensus Conference on Diagnosis and Prognostic Parameters in Localized Prostate Cancer. Stockholm, Sweden, May 12-13, 1993.

Stamey TA, Ekman PE, Blankenstein MA, Cooper EH, Kontturi M, Lilja H, Oesterling JE, Stenman UH, Turkes A. Stamey TA, et al. Among authors: ekman pe. Scand J Urol Nephrol Suppl. 1994;162:73-87; discussion 115-27. Scand J Urol Nephrol Suppl. 1994. PMID: 7529430 Review.

8

Finasteride in the treatment of benign prostatic hypertrophy: an update. New indications for finasteride therapy.

Ekman P. Ekman P. Scand J Urol Nephrol Suppl. 1999;203:15-20. doi: 10.1080/00365599950509997. Scand J Urol Nephrol Suppl. 1999. PMID: 10636564 Review.

9

Pharmacological treatment of benign prostatic hyperplasia with finasteride: a clinical review.

Ekman P. Ekman P. Arch Esp Urol. 1994 Nov;47(9):883-7; discussion 887-8. Arch Esp Urol. 1994. PMID: 7530944 Review.

10

Finasteride in the treatment of benign prostatic hyperplasia.

Ekman P, Andersen JT, Wolf H. Ekman P, et al. Acta Urol Belg. 1996 Mar;64(1):IX-XII. Acta Urol Belg. 1996. PMID: 8659328 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

296 results

Search Page

Filters